
The global market for CTC Detection was valued at US$ 1477 million in the year 2024 and is projected to reach a revised size of US$ 2923 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Circulating Tumor Cell (CTC) detection involves identifying and analyzing tumor cells that have detached from a primary tumor and are circulating in the bloodstream. This method can aid in cancer diagnosis and monitoring.
North American market for CTC Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CTC Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CTC Detection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CTC Detection include Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, Johnson & Johnson, NeoGenomics Laboraories, Guangzhou Wondfo Biotech, TOPGEN, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CTC Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CTC Detection.
The CTC Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CTC Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CTC Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
Johnson & Johnson
NeoGenomics Laboraories
Guangzhou Wondfo Biotech
TOPGEN
Surexam Bio Tech
Wuhan Yzy Medical Science&Technology
GenoSaber Biotech
BGI Genomics
Segment by Type
Immunoaffinity Enrichment
Physical Property Enrichment
Other
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CTC Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CTC Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoaffinity Enrichment
1.2.3 Physical Property Enrichment
1.2.4 Other
1.3 Market by Application
1.3.1 Global CTC Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CTC Detection Market Perspective (2020-2031)
2.2 Global CTC Detection Growth Trends by Region
2.2.1 Global CTC Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CTC Detection Historic Market Size by Region (2020-2025)
2.2.3 CTC Detection Forecasted Market Size by Region (2026-2031)
2.3 CTC Detection Market Dynamics
2.3.1 CTC Detection Industry Trends
2.3.2 CTC Detection Market Drivers
2.3.3 CTC Detection Market Challenges
2.3.4 CTC Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CTC Detection Players by Revenue
3.1.1 Global Top CTC Detection Players by Revenue (2020-2025)
3.1.2 Global CTC Detection Revenue Market Share by Players (2020-2025)
3.2 Global CTC Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CTC Detection Revenue
3.4 Global CTC Detection Market Concentration Ratio
3.4.1 Global CTC Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CTC Detection Revenue in 2024
3.5 Global Key Players of CTC Detection Head office and Area Served
3.6 Global Key Players of CTC Detection, Product and Application
3.7 Global Key Players of CTC Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CTC Detection Breakdown Data by Type
4.1 Global CTC Detection Historic Market Size by Type (2020-2025)
4.2 Global CTC Detection Forecasted Market Size by Type (2026-2031)
5 CTC Detection Breakdown Data by Application
5.1 Global CTC Detection Historic Market Size by Application (2020-2025)
5.2 Global CTC Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CTC Detection Market Size (2020-2031)
6.2 North America CTC Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CTC Detection Market Size by Country (2020-2025)
6.4 North America CTC Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CTC Detection Market Size (2020-2031)
7.2 Europe CTC Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CTC Detection Market Size by Country (2020-2025)
7.4 Europe CTC Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CTC Detection Market Size (2020-2031)
8.2 Asia-Pacific CTC Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CTC Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific CTC Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CTC Detection Market Size (2020-2031)
9.2 Latin America CTC Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CTC Detection Market Size by Country (2020-2025)
9.4 Latin America CTC Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CTC Detection Market Size (2020-2031)
10.2 Middle East & Africa CTC Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CTC Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa CTC Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad CTC Detection Introduction
11.1.4 Bio-Rad Revenue in CTC Detection Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche CTC Detection Introduction
11.2.4 Roche Revenue in CTC Detection Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Biocartis
11.3.1 Biocartis Company Details
11.3.2 Biocartis Business Overview
11.3.3 Biocartis CTC Detection Introduction
11.3.4 Biocartis Revenue in CTC Detection Business (2020-2025)
11.3.5 Biocartis Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen CTC Detection Introduction
11.4.4 Qiagen Revenue in CTC Detection Business (2020-2025)
11.4.5 Qiagen Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Details
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health CTC Detection Introduction
11.5.4 Guardant Health Revenue in CTC Detection Business (2020-2025)
11.5.5 Guardant Health Recent Development
11.6 MDxHealth
11.6.1 MDxHealth Company Details
11.6.2 MDxHealth Business Overview
11.6.3 MDxHealth CTC Detection Introduction
11.6.4 MDxHealth Revenue in CTC Detection Business (2020-2025)
11.6.5 MDxHealth Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson CTC Detection Introduction
11.7.4 Johnson & Johnson Revenue in CTC Detection Business (2020-2025)
11.7.5 Johnson & Johnson Recent Development
11.8 NeoGenomics Laboraories
11.8.1 NeoGenomics Laboraories Company Details
11.8.2 NeoGenomics Laboraories Business Overview
11.8.3 NeoGenomics Laboraories CTC Detection Introduction
11.8.4 NeoGenomics Laboraories Revenue in CTC Detection Business (2020-2025)
11.8.5 NeoGenomics Laboraories Recent Development
11.9 Guangzhou Wondfo Biotech
11.9.1 Guangzhou Wondfo Biotech Company Details
11.9.2 Guangzhou Wondfo Biotech Business Overview
11.9.3 Guangzhou Wondfo Biotech CTC Detection Introduction
11.9.4 Guangzhou Wondfo Biotech Revenue in CTC Detection Business (2020-2025)
11.9.5 Guangzhou Wondfo Biotech Recent Development
11.10 TOPGEN
11.10.1 TOPGEN Company Details
11.10.2 TOPGEN Business Overview
11.10.3 TOPGEN CTC Detection Introduction
11.10.4 TOPGEN Revenue in CTC Detection Business (2020-2025)
11.10.5 TOPGEN Recent Development
11.11 Surexam Bio Tech
11.11.1 Surexam Bio Tech Company Details
11.11.2 Surexam Bio Tech Business Overview
11.11.3 Surexam Bio Tech CTC Detection Introduction
11.11.4 Surexam Bio Tech Revenue in CTC Detection Business (2020-2025)
11.11.5 Surexam Bio Tech Recent Development
11.12 Wuhan Yzy Medical Science&Technology
11.12.1 Wuhan Yzy Medical Science&Technology Company Details
11.12.2 Wuhan Yzy Medical Science&Technology Business Overview
11.12.3 Wuhan Yzy Medical Science&Technology CTC Detection Introduction
11.12.4 Wuhan Yzy Medical Science&Technology Revenue in CTC Detection Business (2020-2025)
11.12.5 Wuhan Yzy Medical Science&Technology Recent Development
11.13 GenoSaber Biotech
11.13.1 GenoSaber Biotech Company Details
11.13.2 GenoSaber Biotech Business Overview
11.13.3 GenoSaber Biotech CTC Detection Introduction
11.13.4 GenoSaber Biotech Revenue in CTC Detection Business (2020-2025)
11.13.5 GenoSaber Biotech Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Details
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics CTC Detection Introduction
11.14.4 BGI Genomics Revenue in CTC Detection Business (2020-2025)
11.14.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
Johnson & Johnson
NeoGenomics Laboraories
Guangzhou Wondfo Biotech
TOPGEN
Surexam Bio Tech
Wuhan Yzy Medical Science&Technology
GenoSaber Biotech
BGI Genomics
Ìý
Ìý
*If Applicable.
